Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lifeline creates subsidiary for breast cancer test

This article was originally published in Clinica

Executive Summary

Reno, Nevada-based Lifeline Biotechnologies has formed a new subsidiary which will focus its efforts on the commercialisation of the firm’s First Warning breast cancer detection system. The creation of the new unit, which will be named First Warning Systems, was prompted when Lifeline filed for patent approval for the technology. The non-imaging system is designed to detect the disease at an early stage by classifying time-related circadian pattern changes in new blood cells supplying a breast cancer. Lifeline claims that the system “records information every five minutes for the duration of the test, collecting over 9,000 data points. The data are then subjected to non-linear algorithmic computer analysis designed to identify abnormalities or disruptions in the normal breast physiology”.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042970

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel